ENTITY

Medexus Pharmaceuticals (MEDXF US)

17
Analysis
Health Care • Canada
Medexus Pharmaceuticals Inc. operates as a pharmaceutical company. The Company focuses on therapeutic areas such as rheumatology, auto-immune disease, specialty oncology, and pediatrics. Medexus Pharmaceuticals serves customers North America and Canada.
more
bullish•Starz
•17 Nov 2025 09:15

Weekly Update (MICC, MEDXF, STRZ)

The Wall Street Journal recently published a good article highlighting that streaming costs are soaring but consumers continue to be willing to...

Logo
282 Views
Share
bullish•Corteva
•06 Oct 2025 09:44

Weekly Update (CTVA, SFGI/8729, UNTC, MEDXF, IDT)

On October 1, 2025, Corteva Biosciences (CTVA) announced that it plans to break up into two public companies. The logic behind the spin-off...

Logo
217 Views
Share
bullish•DuPont
•18 Aug 2025 09:29

Weekly Update (Qnity, MEDXF, STRZ, UNTC)

Dupont (DD) management gave guidance on its last earnings call that it remains on track to separate its electronics business on November 1, 2025.

Logo
377 Views
Share
bullish•Brightstar Lottery
•30 Jun 2025 10:51

Weekly Update (AMRZ, UNTC, MEDXF, IGT)

This week, I recommended a new idea: Buy International Gaming Technologies. If you are interested in buying IGT, I would recommend doing so on Monday.

Logo
332 Views
Share
bullish•Fortive
•09 Jun 2025 09:20

Weekly Update (MEDXF, IDT, FTV)

Fortive (FTV) will spin off 100% of Ralliant on June 28, 2025. Ralliant will trade under the ticker RAL. When issued trading will begin on June 25th.

Logo
406 Views
Share
x